Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Jana Zolkova"'
Autor:
Dana Prídavková, Matej Samoš, Tomáš Bolek, Ingrid Škorňová, Jana Žolková, Peter Kubisz, Ján Staško, Marián Mokáň
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in patients with atrial fibrillation (AF), and T2D patients with AF-associated stroke seem to have worse clinical outcome and higher risk of unfavorable clinical cour
Externí odkaz:
https://doaj.org/article/65a50962082648c3a0445471b3c7e0aa
Publikováno v:
Acta Medica Martiniana, Vol 24, Iss 1, Pp 29-41 (2024)
Hematological malignancies represent a heterogeneous group of diseases that may have overlapping clinical manifestations. Successful and optimal management depends on early and accurate diagnosis of the disease. Differential diagnosis therefore requi
Externí odkaz:
https://doaj.org/article/38e3afa1bfda4ef8b4ed9caebcda2263
Autor:
Monika Brunclikova, Jela Ivankova, Maria Skerenova, Tomas Simurda, Lucia Stanciakova, Ingrid Skornova, Miroslava Sterankova, Jana Zolkova, Miroslava Dobrotova, Pavol Holly, Peter Kubisz, Jan Stasko
Publikováno v:
Acta Medica Martiniana, Vol 22, Iss 1, Pp 34-44 (2022)
Introduction: Inherited platelet hyperaggregability, so called “Sticky platelet syndrome” (SPS), is a prothrombotic platelet disorder. The syndrome contributes more often to arterial than venous thrombosis. The most common localization of arteria
Externí odkaz:
https://doaj.org/article/81cad9474a4041239c0c6896498e153f
Autor:
Miroslava Drotarova, Jana Zolkova, Kristina Maria Belakova, Monika Brunclikova, Ingrid Skornova, Jan Stasko, Tomas Simurda
Publikováno v:
Diagnostics, Vol 13, Iss 20, p 3219 (2023)
Rotational thromboelastometry (ROTEM) is a viscoelastic method, which provides a graphical and numerical representation of induced hemostasis in whole blood samples. Its ability to quickly assess the state of hemostasis is used in the management of b
Externí odkaz:
https://doaj.org/article/b59dfeee6170445ba1ab50d5dda803f4
Autor:
Lucia Stanciakova MD, PhD, Miroslava Dobrotova MD, PhD, Pavol Holly MD, PhD, Jana Zolkova MSc, PhD, Lubica Vadelova MSc, PhD, Ingrid Skornova MA, PhD, Jela Ivankova MSc, Matej Samos MD, PhD, Tomas Bolek MD, PhD, Marian Grendar MSc, PhD, Jan Danko MD, PhD, Peter Kubisz MD, DSc, Jan Stasko MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE ) . Anyway, there is only limited amount of studies evaluating the effect of LMWH on hemostatic parameters during preg
Externí odkaz:
https://doaj.org/article/1446eff435f34e45a8e508419e73fd28
Autor:
Juraj Sokol MD, PhD, Frantisek Nehaj MD, Jela Ivankova RNDr, Michal Mokan MD, PhD, Jana Zolkova RNDr, Lenka Lisa MD, PhD, Ludmila Linekova MD, Marian Mokan MD, DSc, FRCP Edin, Jan Stasko MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
A rapid and reliable assessment of the dabigatran effect is desirable in dabigatran treated patients with uncontrolled bleeding or before acute surgery. The aim of this study was to study the anticoagulant effects of dabigatran in patients with atria
Externí odkaz:
https://doaj.org/article/45ffc6ca78f2438e8496473c24f36106
Autor:
Juraj Sokol MD, PhD, Frantisek Nehaj MD, Jela Ivankova RNDr, Michal Mokan MD, PhD, Lenka Lisa MD, PhD, Jana Zolkova RNDr, Lubica Vadelova RNDr, Marian Mokan Prof, MD, DSc, FRCP Edin, Jan Stasko Prof, MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Edoxaban, a direct factor Xa inhibitor (FXa), is the fourth direct oral anticoagulant (DOAC) approved for clinical use. As the main adverse event is bleeding, it is relevant whether edoxaban has additional effects on platelet function. We aimed to as
Externí odkaz:
https://doaj.org/article/90ee2f85093240908bd3f4c5594d9b6e
Autor:
Tomas Simurda, Rosanna Asselta, Jana Zolkova, Monika Brunclikova, Miroslava Dobrotova, Zuzana Kolkova, Dusan Loderer, Ingrid Skornova, Jan Hudecek, Zora Lasabova, Jan Stasko, Peter Kubisz
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2140 (2021)
Congenital fibrinogen disorders are rare pathologies of the hemostasis, comprising quantitative (afibrinogenemia, hypofibrinogenemia) and qualitative (dysfibrinogenemia and hypodysfibrinogenemia) disorders. The clinical phenotype is highly heterogene
Externí odkaz:
https://doaj.org/article/1b2962a9071f4dddb96c55543b50554b
Autor:
Ingrid Skornova, Tomas Simurda, Jan Stasko, Jana Zolkova, Juraj Sokol, Pavol Holly, Miroslava Dobrotova, Ivana Plamenova, Jan Hudecek, Monika Brunclikova, Alena Stryckova, Peter Kubisz
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2153 (2021)
von Willebrand disease (VWD) is reportedly the most common inherited bleeding disorder. This disorder develops as a result of defects and/or deficiency of the plasma protein von Willebrand factor (VWF). Laboratory testing for VWF-related disorders re
Externí odkaz:
https://doaj.org/article/044a479f87c64ae6989a805ed7e053f0
Autor:
Lucia Stanciakova, Miroslava Dobrotova, Pavol Holly, Jana Zolkova, Lubica Vadelova, Ingrid Skornova, Jela Ivankova, Tomas Bolek, Matej Samos, Marian Grendar, Jan Danko, Peter Kubisz, Jan Stasko
Publikováno v:
Diagnostics, Vol 11, Iss 5, p 828 (2021)
Thromboprophylaxis with low-molecular-weight heparin (LMWH) for patients with a history of venous thromboembolism (VTE) is suggested. Rotational thromboelastometry (ROTEM®) represents an innovative point-of-care method enabling the complex and quick
Externí odkaz:
https://doaj.org/article/d3b778e32d9946dc82b545930afbb383